Indispensable role of β-arrestin2 in the protection of remifentanil preconditioning against hepatic ischemic reperfusion injury
Open Access
- 14 February 2019
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 9 (1), 1-9
- https://doi.org/10.1038/s41598-018-38456-9
Abstract
Our previous study demonstrated that remifentanil, an opioid agonist, conferred profound liver protection during hepatic ischemia reperfusion injury (HIRI), in which Toll-like receptors (TLRs) played a crucial role in mediating the inflammatory responses. β-arrestin2, a well-known mu opioid receptor desensitizer, is also a negatively regulator of Toll-like receptor 4 (TLR4)-mediated inflammatory reactions in a mitogen-activated protein kinase (MAPK)-dependent manner. Using the rodent models of hepatic ischemia reperfusion injury both in wild type and TLR4 knockout (TLR4 KO) mice, we found that remifentanil preconditioning could inhibit the expression of TLR4 and reduce the inflammatory response induced by HIRI in wild type but not in TLR4 KO mice. For the in-vitro study, LPS was used to treat RAW264.7 macrophage cells to mimic the inflammatory response induced by HIRI. Remifentanil increased β-arrestin2 expression both in vivo and in vitro, while after silencing β-arrestin2 RNA, the effect of remifentanil in reducing cell death and apoptosis, as well as decreasing phosphorylation of ERK and JNK were abolished in RAW264.7 cells. These data suggested that remifentanil could ameliorate mice HIRI through upregulating β-arrestin2 expression, which may function as a key molecule in bridging opioid receptor and TLR4 pathway.Keywords
Funding Information
- National Natural Science Foundation of China (81471846 and 2017BR042)
This publication has 48 references indexed in Scilit:
- Surfactant Protein-A Modulates LPS-Induced TLR4 Localization and Signaling via β-Arrestin 2PLOS ONE, 2013
- Opioid Activation of Toll-Like Receptor 4 Contributes to Drug ReinforcementJournal of Neuroscience, 2012
- Remifentanil Preconditioning Reduces Hepatic Ischemia–Reperfusion Injury in Rats via Inducible Nitric Oxide Synthase ExpressionAnesthesiology, 2011
- Down‐Regulation of TNF‐Alpha by Small Interfering RNA Inhibits Particle‐Induced Inflammation In VitroArtificial Organs, 2011
- Reactive oxygen and mechanisms of inflammatory liver injury: Present conceptsJournal of Gastroenterology and Hepatology, 2011
- β-Arrestins facilitate ubiquitin-dependent degradation of apoptosis signal-regulating kinase 1 (ASK1) and attenuate H2O2-induced apoptosisCellular Signalling, 2009
- Mechanisms of Toll-Like Receptor 4 (TLR4)-Mediated Inflammation After Cold Ischemia/Reperfusion in the HeartTransplantation, 2009
- JNK mediates hepatic ischemia reperfusion injuryJournal of Hepatology, 2005
- Design and validation of a histological scoring system for nonalcoholic fatty liver diseaseHepatology, 2005
- Identification of β-Arrestin2 as a G Protein-Coupled Receptor-Stimulated Regulator of NF-κB PathwaysMolecular Cell, 2004